Parametric Portfolio Associates LLC grew its position in PerkinElmer, Inc. (NYSE:PKI) by 9.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 231,715 shares of the medical research company’s stock after purchasing an additional 19,361 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.21% of PerkinElmer worth $15,981,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Acrospire Investment Management LLC increased its position in PerkinElmer by 185.7% during the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the medical research company’s stock worth $136,000 after acquiring an additional 1,300 shares during the period. Waldron LP bought a new position in PerkinElmer during the third quarter worth $200,000. Seaward Management Limited Partnership bought a new position in PerkinElmer during the third quarter worth $202,000. Carret Asset Management LLC bought a new position in PerkinElmer during the second quarter worth $210,000. Finally, Cipher Capital LP bought a new position in PerkinElmer during the second quarter worth $230,000. 91.37% of the stock is currently owned by institutional investors.
PKI has been the topic of a number of research reports. Robert W. Baird boosted their target price on shares of PerkinElmer from $75.00 to $78.00 and gave the stock an “outperform” rating in a research report on Friday, November 3rd. Zacks Investment Research raised shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 target price on the stock in a research report on Monday, January 8th. Morgan Stanley boosted their price target on shares of PerkinElmer from $77.00 to $78.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Jefferies Group reissued a “hold” rating and issued a $70.00 price target on shares of PerkinElmer in a report on Friday, October 20th. Finally, Goldman Sachs Group reissued a “neutral” rating and issued a $67.00 price target on shares of PerkinElmer in a report on Tuesday, September 26th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $72.29.
Shares of PerkinElmer, Inc. (NYSE:PKI) opened at $78.89 on Friday. PerkinElmer, Inc. has a 52 week low of $50.59 and a 52 week high of $79.02. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44. The company has a market cap of $8,555.68, a price-to-earnings ratio of 21.91, a PEG ratio of 1.87 and a beta of 0.77.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.35%. PerkinElmer’s dividend payout ratio is presently 7.78%.
In other news, Director Peter Barrett sold 7,071 shares of the business’s stock in a transaction on Monday, November 13th. The shares were sold at an average price of $71.07, for a total value of $502,535.97. Following the sale, the director now owns 26,271 shares in the company, valued at approximately $1,867,079.97. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nicholas A. Lopardo sold 24,050 shares of the business’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $70.72, for a total transaction of $1,700,816.00. The disclosure for this sale can be found here. Insiders sold a total of 86,336 shares of company stock worth $6,114,917 in the last 90 days. 2.20% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2018/01/14/parametric-portfolio-associates-llc-buys-19361-shares-of-perkinelmer-inc-pki.html.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.